top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antitumoral Properties of Natural Products : Volume 2
Antitumoral Properties of Natural Products : Volume 2
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (300 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 13-ethylberberine
Akt
AKT
anthraquinones
anti-cancer
anti-cancer activity
anti-cancer agents
anti-tumor activity
anticancer
Antioxidant activities
antioxidants
antioxidation
antiproliferation agents
Antiproliferative
antiproliferative activity
antitumoral activity
antrodin C
apoptosis
AR
Artemisia absinthium
ASE
Aspergillus fumigatus
ATM-Chk2
autophagic flux inhibition
autophagy
bee venom
betulinic acid
Brazilian Cerrado biome
cancer
cancer stem cells
capsazepine
carrageenan
Catalpa speciosa
Celastraceae
cell cycle arrest
cell proliferation
cell signaling
cephalotaxine
cervical cancer
Cheiloclinium cognatum
chemotherapeutic adjuvant
chemotherapy
chiral resolution
CIP2A
CLE-10
CLEFMA
Colocasia esculenta
colorectal cancer cells
copper
Cordyceps sinensis
coronarin D
CrataBL
cryptolepine
Cucurbitacin B
cytotoxic activity
cytotoxicity
Dendrobium officinale
diallyl disulfide
dicentrine
DLD-1 cells
doxorubicin
drug resistance
ECD calculation
EGFR
endoplasmic reticulum stress
entrapment efficiency
Euphorbia tirucalli
FAK/S6K1
flavonoids
folk medicine
food bioactive
FOXO1
fruit
Ganoderma tsugae
gastric cancer
gastric cancer cells
gefitinib-resistant NSCLC
Gene expression
glioblastoma
glioblastoma multiforme
glioma
glucose uptake
glycosyltransferase
grape leaves
human neuroblastoma cells
IL-6/JAK2/STAT3
inflammation
inflammatory diseases
ingenol
invasion
isochromanes
isocryptolepine
JNK
lactoferrin hydrolysate
LC3
lichen
Licochalcone A
lipogenesis
lung adenocarcinoma
lysosomal degradation
lysosomal membrane permeabilization
Magnolia acuminata
manganese
MAPK
MCF-7 cells
MDA-MB-231
melanoma
melittin
mesenchymal stem cells
metabolic stability
metastasis
microenvironment
migration
mitochondrial membrane potential
mitochondrial ROS
mitochondrial-dependent pathway
molecular mechanism
mTOR
multiple myeloma
n/a
naringenin
natural compounds
natural product alkaloids
natural products
natural yellow Monascus pigments
NCI-60 cancer cell line
necrotic
neferine
neocryptolepine
NF-κB
no-toxicity
Nutraceuticals
oncogene
osteosarcoma
p38
patuletin
phenols
phloretin
phytochemicals
PI3K/AKT/mTOR
PI3K/Akt/mTOR pathway
plant lectin
plant-derived foods
plantation mode
Plenckia populnea
porphyran
preclinical tests
pristimerin
pro-apoptotic effects
proanthocyanins
prostate cancer
protease inhibitor
protein kinase C
protein synthesis inhibition
Pulsatilla saponin D
quality control
quercetagetin
quercetin
ROS
RT-R breast cancer cells
Salacia crassifolia
Salacia elliptica
SB365
seaweed
secondary metabolites
semi-synthetic derivative
SREBP-1
stable nanocapsules
stemness potential
structure activity relationships
structure elucidation
tarin
Taxus cuspidata
temozolomide
TNF-α
TP
traditional preparation
transcriptional regulation
triterpenoids
TRPV1
tumidulin
ursolic acid
vegetable
water-soluble
zerumbone
Zeylenone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Antitumoral Properties of Natural Products
Record Nr. UNINA-9910557531303321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumoral Properties of Natural Products
Antitumoral Properties of Natural Products
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (344 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 13-ethylberberine
Akt
AKT
anthraquinones
anti-cancer
anti-cancer activity
anti-cancer agents
anti-tumor activity
anticancer
Antioxidant activities
antioxidants
antioxidation
antiproliferation agents
Antiproliferative
antiproliferative activity
antitumoral activity
antrodin C
apoptosis
AR
Artemisia absinthium
ASE
Aspergillus fumigatus
ATM-Chk2
autophagic flux inhibition
autophagy
bee venom
betulinic acid
Brazilian Cerrado biome
cancer
cancer stem cells
capsazepine
carrageenan
Catalpa speciosa
Celastraceae
cell cycle arrest
cell proliferation
cell signaling
cephalotaxine
cervical cancer
Cheiloclinium cognatum
chemotherapeutic adjuvant
chemotherapy
chiral resolution
CIP2A
CLE-10
CLEFMA
Colocasia esculenta
colorectal cancer cells
copper
Cordyceps sinensis
coronarin D
CrataBL
cryptolepine
Cucurbitacin B
cytotoxic activity
cytotoxicity
Dendrobium officinale
diallyl disulfide
dicentrine
DLD-1 cells
doxorubicin
drug resistance
ECD calculation
EGFR
endoplasmic reticulum stress
entrapment efficiency
Euphorbia tirucalli
FAK/S6K1
flavonoids
folk medicine
food bioactive
FOXO1
fruit
Ganoderma tsugae
gastric cancer
gastric cancer cells
gefitinib-resistant NSCLC
Gene expression
glioblastoma
glioblastoma multiforme
glioma
glucose uptake
glycosyltransferase
grape leaves
human neuroblastoma cells
IL-6/JAK2/STAT3
inflammation
inflammatory diseases
ingenol
invasion
isochromanes
isocryptolepine
JNK
lactoferrin hydrolysate
LC3
lichen
Licochalcone A
lipogenesis
lung adenocarcinoma
lysosomal degradation
lysosomal membrane permeabilization
Magnolia acuminata
manganese
MAPK
MCF-7 cells
MDA-MB-231
melanoma
melittin
mesenchymal stem cells
metabolic stability
metastasis
microenvironment
migration
mitochondrial membrane potential
mitochondrial ROS
mitochondrial-dependent pathway
molecular mechanism
mTOR
multiple myeloma
n/a
naringenin
natural compounds
natural product alkaloids
natural products
natural yellow Monascus pigments
NCI-60 cancer cell line
necrotic
neferine
neocryptolepine
NF-κB
no-toxicity
Nutraceuticals
oncogene
osteosarcoma
p38
patuletin
phenols
phloretin
phytochemicals
PI3K/AKT/mTOR
PI3K/Akt/mTOR pathway
plant lectin
plant-derived foods
plantation mode
Plenckia populnea
porphyran
preclinical tests
pristimerin
pro-apoptotic effects
proanthocyanins
prostate cancer
protease inhibitor
protein kinase C
protein synthesis inhibition
Pulsatilla saponin D
quality control
quercetagetin
quercetin
ROS
RT-R breast cancer cells
Salacia crassifolia
Salacia elliptica
SB365
seaweed
secondary metabolites
semi-synthetic derivative
SREBP-1
stable nanocapsules
stemness potential
structure activity relationships
structure elucidation
tarin
Taxus cuspidata
temozolomide
TNF-α
TP
traditional preparation
transcriptional regulation
triterpenoids
TRPV1
tumidulin
ursolic acid
vegetable
water-soluble
zerumbone
Zeylenone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557419703321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug Delivery of siRNA Therapeutics
Drug Delivery of siRNA Therapeutics
Autore Lamberti Gaetano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (288 p.)
Soggetto topico Medicine
Soggetto non controllato AKT
amphiphilic dendrons
angiogenesis
antitumor effect
aptamers
asthma
BCL2
BIRC5/survivin
breast cancer
cancer
carbonate apatite
cationic cholesterol derivative
cationic liposome
clinical trials
covalent dendrimers
delivery
drug co-delivery
drug delivery
endoglin
endothelial cells
ERBB2
folate
folate receptor
gene knockdown
gene silencing
indocyanine green
intracellular release
iron oxide
light-activated release
lipid
liposome
liposomes
magnetic nanoparticle
methotrexate
migration
mixed micelles
n/a
NABDs
nanoparticle
nanoparticles
nanovectors
oligonucleotide delivery
oral cancer
ovarian cancer
PAMAM dendrimers
pegylation
PEI
peptide
poly(ethylene) imine
polyamine
polyaspartamide
polymer
polyplexes
proliferation
RNA
RNAi therapeutics
self-assembling
siRNA
siRNA delivery
STAT6
targeted delivery system
tumor xenograft
tumor-targeting
tyrosine-modification
VEGFA
VEGFR1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557498903321
Lamberti Gaetano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
Autore Holzmann Klaus
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (276 p.)
Soggetto topico Medicine
Soggetto non controllato adenocarcinoma of the esophagogastric junction
AKT
anticancer
astrocytoma
autocrine signaling
autophagy
brain cancer
breast cancer
cancer
cancer signaling
cancer-associated fibroblasts
coreceptor
ERK
ERK1/2
estrogen
FGF
FGF-mediated signaling
FGF18
FGF19
FGF2
FGF8
FGFR
FGFR1
FGFR2
FGFR2c
FGFR4
fibroblast growth factor
fibroblast growth factor receptors
FRS2
gastric cancer
gene regulation
GPER
HCC
HEK293
immunohistochemistry
infigratinib sensitivity
inhibitors
JNK1
keratinocyte
kinase inhibitor
LY2874455
malignant glioma
malignant pleural mesothelioma
melanoma
membrane proteins
monoclonal antibody
MTOR
n/a
negative feedback loop
neoadjuvant therapy
neurite outgrowth
NVP-BGJ398
optogenetics
overall survival
PC12
phosphorylation
prognosis
receptor cross-talk
receptor kinase
resistance
review
sarcoma
seborrheic keratosis
serine
signaling
skin
small molecule
Sprouty proteins
squamous and basal cell carcinoma
structure
targeted therapy
tumor promoter
tumor suppressor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Fibroblast Growth Factor Receptor
Record Nr. UNINA-9910557898903321
Holzmann Klaus  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
mTOR in Human Diseases / Olivier Dormond
mTOR in Human Diseases / Olivier Dormond
Autore Dormond Olivier
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (480 p.)
Soggetto topico Medicine
Soggetto non controllato primary cilia
neurodegeneration
nutrient sensor
PI3K
transcriptomics
phosphorylation
metabolic reprogramming
autophagy
Alzheimer's disease
rapalogs
liver
angiogenesis
mTOR complex
MBSCs
advanced biliary tract cancers
Medulloblastoma
epithelial to mesenchymal transition
AMPK
p70S6K
lipid metabolism
thyroid cancer
sodium iodide symporter (NIS)/SLC5A5
male fertility
anesthesia
illumina
mTOR inhibitor
miRNA
Hutchinson-Gilford progeria syndrome (HGPS)
eIFs
Emery-Dreifuss muscular dystrophy (EDMD)
glucose
AKT
oral cavity squamous cell carcinoma (OSCC)
glucose and lipid metabolism
cellular signaling
aging
tumor microenvironment
rapamycin
leukemia
chloral hydrate
rapalogues
schizophrenia
T-cell acute lymphoblastic leukemia
senescence
lamin A/C
neurotoxicity
neurodevelopment
inhibitor
methamphetamine
pulmonary fibrosis
mTOR
mTOR inhibitors
combination therapy
proteolysis
fluid shear stress
tumour cachexia
biomarkers
synapse
gluconeogenesis
mTOR signal pathway
Sertoli cells
immunosenescence
miRNome
protein aggregation
senolytics
metabolism
NGS
mTORC2
mTORC1
metabolic diseases
IonTorrent
apoptosis
dopamine receptor
nocodazole
microenvironment
everolimus
acute myeloid leukemia
immunotherapy
spermatogenesis
bone remodeling
signalling
targeted therapy
ageing
therapy
NVP-BEZ235
fructose
physical activity
laminopathies
MC3T3-E1 cells
cell signaling
microRNA
cancer
lipolysis
melatonin
Parkinson's disease
ISBN 9783039210619
3039210610
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346684303321
Dormond Olivier  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (294 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acetyltransferase
AKT
antigen processing machinery (APM) molecules
AR
biomarker
biomarkers
bladder cancer
blood
BRCA1/2
breast cancer
cancer
cancer immunotherapy
cancer prognosis
carcinogenesis
cardioncology
cardiotoxicity
castration-resistant prostate cancer (CRPC)
CD8+ T effector cells
chemo-/radio resistance
CSC
CTCs
cytokines
EMT
eribulin
genetic syndromes
genomic mutations
head and neck cancer
head and neck neoplasms
head and neck tumors
HRR
HUB nodes
human leukocyte antigen (HLA)
hyperglycemia
immune checkpoint inhibitor
K-RAS oncogene
laryngeal cancer
lifestyle habit
major histocompatibility complex (MHC)
MAPK
melanoma
melanoma resistance to MAPK/MEK inhibitors
metabolomics
metastasis
microRNA
miRNA
MSI2
mTOR
musashi 2
mutations
N-cadherin
n/a
NAA10
new metastasis
nivolumab
oncogene dependency
oral cancer
OSCC
pancreatic cancer
paraganglioma
PDL1
pheochromocytoma
PI3K
PI3KCA
prediction
prognosis
prostate cancer
PTEN
resistance to immune checkpoint inhibitors
selenoproteins
targeted therapies
therapeutic resistance
therapeutic target
TILs
TNBC
transcriptomics
tumor predisposition
WNT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Natural-based Biomolecules Discovery for Tackling Chronic Diseases
Novel Natural-based Biomolecules Discovery for Tackling Chronic Diseases
Autore Kwok Hang Fai
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (180 p.)
Soggetto topico Humanities
Social interaction
Soggetto non controllato AKT
amphibian Bowman-Birk inhibitor
amyloidogenesis
anionic lipids
anti-inflammation
anticancer therapy
anticancer therapy/cancer treatment
antifungal
antioxidant
apoptosis
Asteraceae
Astragalus membranaceus
Bcl-2 family proteins
binding affinity
branched-chain fatty acids
cell cycle arrest
colorectal cancer
Conidiobolus heterosporus
COX-2
DAPK1
docetaxel
drug delivery system
drug design
endoplasmic reticulum
F23R variant
fatty acid oxidation
fibroblasts
fucoidan
G-protein activation
gingiva
hepatocyte
hIAPP
iNOS
insulin
insulin granules
kynurenines
lignan
lipid metabolism
lung cancer
molecular cloning
molecular docking
n/a
natural-based compound
NO
orientin
PDX-1
peptides
peroxisome proliferator-activated receptor α
Petasites japonicus
PGE2
pharmacophore
PI3K
PLGA
pomegranate
post-translational modification
PPARγ
protease inhibitor
protein degradation
punicalagin
SENP
STAT3
SUMO
survivin
tannins
Tat peptide
unfolded protein response
wound healing
β-cell cytotoxicity
β-sheet transitions
μ-opioid receptor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557607403321
Kwok Hang Fai  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers : Volume 2
Autore Luparello Claudio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (318 p.)
Soggetto topico Biology, life sciences
Research and information: general
Soggetto non controllato acute myeloid leukemia
adipocyte inflammation
AKT
AMPK
angiogenesis
anti-cancer drug
anti-proliferative
anticancer
anticancer activities
anticancer drug
anticancer drugs
AOM/DSS model
apoptosis
autophagy
berberine
Berthel
bioactivities
bioavailability
brain cancer
breast cancer
breast cancer cells
breast cancer prognostic
breast cancer risk
Calocedrus formosana
cancer
cancer metabolism
cancer stem cell
cancer therapy
carrageenan
caspase-independent cell death
cell death
cell signaling
cell-cycle arrest
chemoprevention
colchicine alkaloid
colon cancer
colon cancer cells
colorectal cancer
daidzein
daidzein metabolites
drugs
EGCG
EGFR signaling
EGFR TKI
eicosapentaenoic acid
epigallocatechin-3-gallate (EGCG)
epithelial mesenchymal transition
ER stress
estrogen
estrogen receptor alpha
ethanol
experimental therapeutics
FASN inhibitors
flavonoids
formononetin
fucoidan
G2/M arrest
gallic acid
gemcitabine
gigantol
gliomas
glucose transport
glycolysis
glycolytic markers
HDAC
HO-1
honokiol
human cancer cells
immunotherapy
inflammation
innate immunity
invasion
isobolography
isorhamnetin
JAK/STAT
lung cancer
malignant cancer
malignant tumors of the peripheral nerve sheath (MPNST)
Malva pseudolavatera Webb &
mangrove
marine sponge
mechanism
melanoma cells
mesoporous silica nanoparticles
metastasis
microRNAs
MMPs
molecular mechanisms
multiple myeloma
n/a
nanoparticle-based delivery systems
natural anti-inflammatory compounds
natural bioactive compound
natural compounds
natural polyphenols
natural product
neurofibromas
nicotine
nobiletin
non-coding RNAs
Nrf2
NSCLC
nutrition
obesity
oleacein
oleuropein
olive leaf extract
oncogenic cascades
oral cancer inhibition
p53
paclitaxel
pancreatic cancer
PD-1 immune checkpoint inhibitor and cancer immunotherapy
PD-L1
persistent organic pollutants
phosphofructokinase
phytochemicals
Piper eriopodon, alkenylphenols
polyphenols
preclinical models
pro-resolving lipids
proteomics
RacGAP1
radiotherapy
reactive oxygen species
renin-angiotensin system
resistance
ROS
schwannomas
Seahorse analysis
signaling pathways
signalling pathway
small organic agents
STAT3
Streptomyces
systematic review
targeted delivery system
TRAIL
tumor density
tumor maintenance
uterine sarcoma
xenograft
Xenopus laevis
XIAP antagonists
XIAP-BIR3 domain
yatein
α9-nAChR
β-glucans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Role of Natural Bioactive Compounds in the Rise and Fall of Cancers
Record Nr. UNINA-9910557476303321
Luparello Claudio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (578 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato ADAM17
adoptive T cell therapy
AKT
androgens
apoptosis
autoimmune disease
autosomal-dominant hyper IgE syndrome
Bone Marrow Failure Syndromes
breast cancer
cancer
cancer models
cancer progression
cancer-stem cell
CD38
CD4+ T cells
CD8+ T cells
cell cycle
cell hierarchy
chaperones
chemotherapy resistance
cirrhosis
colon cancer
companion animals
comparative oncology
cytokine
cytokine receptor signaling
dynamic programming
endoplasmic reticulum (ER) stress
epidermal growth factor receptor (EGF-R)
ERK1/2
escape mechanisms
gain-of-function mutation
glioblastoma
glioma
growth hormone insensitivity syndrome
heat shock proteins
hedging
hematopoietic cancers
hepatitis C virus (HCV)
hepatocellular carcinoma (HCC)
hepatocyte nuclear factor 4 alpha (HNF4A)
immune check point
immune suppression
immunosuppression
immunotherapy
inflammation
inflammation associated cancer
inflammatory hepatocellular adenomas
interleukin-6
JAK
JAK family of protein tyrosine kinases
JAK2 V617F
knockout
lipopolyplex
lung cancer
lymphocytes
lymphoma
M2 macrophages
melanoma
meta-analysis
metalloprotease
metastasis
microRNA-122 (miR-122)
mitochondria
MPN
mTOR
multiple myeloma
mutations
myeloid cells
myeloid leukemia
n/a
nanoparticle
neoplastic stem cells
NGS
NK cells
nuclear factor erythroid 2-related factor 2 (NRF2)
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
ovarian cancer
oxidative stress (OS)
PD-L1
PEI
pharmacological inhibitor
pharmacological inhibitors
polyethylenimine
post-decision state variable
prolactin
proliferation
prostate cancer
RHOA
risk management
S3I-1757
SH2 domain
shedding
signal transducer and activator of transcription
signal transducer and activator of transcription 3 (STAT3)
siRNA delivery
siRNA/RNAi
small-molecule inhibitors
solid cancers
stabilization
STAT
STAT transcription factors
STAT3
STAT3 inhibitor XIII
STAT5
STAT5 signaling
STAT5B signaling
stem/progenitor cells
stemness
T-cell large granular lymphocytic leukemia
T-cell leukemia
T-cell prolymphocytic leukemia
T-cells
T-PLL
targeted therapy
targeting
therapeutic targeting
therapy resistance
trans-signaling
transaction costs
tumor microenvironment
tumor necrosis factor alpha (TNFα)
tumor suppression
tumor-associated macrophages
tumor-immune cell interactions
tumorigenesis
tyrosine kinase 2
unfolded protein response (UPR)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui